verified SJR 0,493 · Q2 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q2 — Biotechnology lock Subscription

Current Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology is a journal indexed in SJR in Biotechnology and Pharmaceutical Science with an H index of 101. It has an SJR impact factor of 0,493 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,493.

ISSN: 1389-2010

Publisher: Bentham Science Publishers

Category: Biotechnology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,493 Q2

H-index 101

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,493

H-index

101

Docs (year)

165

Docs 3y

470

Total refs

16951

Cites 3y

1297

Citable 3y

451

Cites/Doc 2y

2.91

Ref/Doc

102.73

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Apigenin alleviates renal fibroblast activation through AMPK and ERK signaling pathways in vitro

Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer

Detection of Tumor Markers with ProteinChip® Technology

Cytokines in Candidiasis and Aspergillosis

By Passing Microbial Resistance: Xylitol Controls Microorganisms Growth by Means of Its Anti-Adherence Property

Biotherapy for Autoimmune Liver Diseases

Biotechnological Approaches for the Production of Pharmaceutically Important Compound: Plumbagin

Biologics in Systemic Sclerosis

Biologics in Polymyositis and Dermatomyositis-Associated Interstitial Lung Disease

Bifunctional Penicillin-Binding Proteins: Focus on the Glycosyltransferase Domain and its Specific Inhibitor Moenomycin

Avermectin Use in Aquaculture

Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer

SHOW MORE ARTICLES

Application of Carbon Monoxide for Transplantation

"Current Biotechnological Approaches for Studying G Protein Coupled Receptor Structure, Function and Signaling"

Antimicrobial Chitosan based Formulations with Impact on Different Biomedical Applications

Antimicrobial and Antiparasitic Activity of Lectins

Anti-CD20 Antibody in Primary Sjogren's Syndrome Management

An Oligodeoxynucleotide with CCT Repeats Restrains CpG ODN-Induced TLR9 Trafficking

Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations

Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology

Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic Support

Accounting for Triplet and Saturation Effects in FCS Measurements

A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic

A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem

FAQs

Current Pharmaceutical Biotechnology has an SJR of 0,493 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Pharmaceutical Biotechnology is 25%.

Current Pharmaceutical Biotechnology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Pharmaceutical Biotechnology?

What is the APC / publication cost?

What is the acceptance rate?